Home/Filings/4/0001333277-18-000031
4//SEC Filing

TRUEX PAUL F 4

Accession 0001333277-18-000031

CIK 0001042074other

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 5:45 PM ET

Size

5.3 KB

Accession

0001333277-18-000031

Insider Transaction Report

Form 4
Period: 2018-01-24
TRUEX PAUL F
Director
Transactions
  • Award

    Stock Option (right to buy)

    2018-01-24+16,00016,000 total
    Exercise: $11.69Exp: 2028-01-23Common Stock (16,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 1/12 of the underlying shares monthly beginning January 1, 2018.

Issuer

CymaBay Therapeutics, Inc.

CIK 0001042074

Entity typeother

Related Parties

1
  • filerCIK 0001120362

Filing Metadata

Form type
4
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 5:45 PM ET
Size
5.3 KB